Allison A. Gockley

Obstetrics and Gynecology
2014 Washington St
Newton, MA 02462

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications

Whole Genome HPV Liquid Biopsy for HPV-Associated Cancer Detection and Viral Physical State Classification.

Whole Genome HPV Liquid Biopsy for HPV-Associated Cancer Detection and Viral Physical State Classification.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 04, 2026

Same day discharge after minimally invasive interval debulking surgery in advanced stage ovarian cancer.

Same day discharge after minimally invasive interval debulking surgery in advanced stage ovarian cancer.

Journal: Gynecologic oncology
Published: November 08, 2025

Neoadjuvant Chemotherapy, Case Volume, and Mortality in Advanced Ovarian Cancer.

Neoadjuvant Chemotherapy, Case Volume, and Mortality in Advanced Ovarian Cancer.

Journal: JAMA network open
Published: July 25, 2025

Decline in Rate of Radical Hysterectomies Performed by Gynecologic Oncologists in the United States.

Decline in Rate of Radical Hysterectomies Performed by Gynecologic Oncologists in the United States.

Journal: Obstetrics and gynecology
Published: April 07, 2025

Utilization of Primary Cytoreductive Surgery for Advanced-Stage Ovarian Cancer.

Utilization of Primary Cytoreductive Surgery for Advanced-Stage Ovarian Cancer.

Journal: JAMA network open
Published: October 16, 2024

The association of maintenance hormone therapy with overall survival in advanced-stage low-grade serous ovarian carcinoma: A risk-set matched retrospective study.

The association of maintenance hormone therapy with overall survival in advanced-stage low-grade serous ovarian carcinoma: A risk-set matched retrospective study.

Journal: Gynecologic oncology
Published: April 27, 2024

Trends in the use of neoadjuvant chemotherapy for low-grade serous ovarian cancer in the United States.

Trends in the use of neoadjuvant chemotherapy for low-grade serous ovarian cancer in the United States.

Journal: Gynecologic oncology
Published: April 03, 2023

Heterogeneity of outcomes of endometrial cancer patients included in prospective clinical trials.

Heterogeneity of outcomes of endometrial cancer patients included in prospective clinical trials.

Journal: Gynecologic oncology
Published: August 03, 2022

Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer.

Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer.

Journal: JAMA oncology
Published: July 28, 2022

Dostarlimab for recurrent mismatch repair-deficient endometrial cancer: A cost-effectiveness study.

Dostarlimab for recurrent mismatch repair-deficient endometrial cancer: A cost-effectiveness study.

Journal: BJOG : an international journal of obstetrics and gynaecology
Published: July 07, 2022

Patterns of cervical cancer screening follow-up in the era of prolonged screening intervals.

Patterns of cervical cancer screening follow-up in the era of prolonged screening intervals.

Journal: Gynecologic oncology
Published: June 17, 2022

Utilization and outcomes of adjuvant therapy for stage II and III uterine leiomyosarcoma.

Utilization and outcomes of adjuvant therapy for stage II and III uterine leiomyosarcoma.

Journal: Gynecologic oncology
Published: April 05, 2022
Showing 1-12 of 73

Last Updated: 09/26/2026